CCG273441
|
C647402-5mg
|
≥98% |
2750414-35-6 |
5mg
|
¥ 2650.9
|
期货,请咨询 |
阿拉丁 |
CCG273441
|
C647402-25mg
|
≥98% |
2750414-35-6 |
25mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
CCG273441
|
C647402-10mg
|
≥98% |
2750414-35-6 |
10mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
CDDO-EA
|
C647396-5mg
|
≥99% |
932730-51-3 |
5mg
|
¥ 2600.9
|
期货,请咨询 |
阿拉丁 |
CDDO-EA
|
C647396-50mg
|
≥99% |
932730-51-3 |
50mg
|
¥ 14000.9
|
期货,请咨询 |
阿拉丁 |
CDDO-EA
|
C647396-1mg
|
≥99% |
932730-51-3 |
1mg
|
¥ 990.9
|
期货,请咨询 |
阿拉丁 |
CDDO-EA
|
C647396-10mg
|
≥99% |
932730-51-3 |
10mg
|
¥ 4700.9
|
期货,请咨询 |
阿拉丁 |
CDDO-EA
|
C647396-100mg
|
≥99% |
932730-51-3 |
100mg
|
¥ 21000.9
|
期货,请咨询 |
阿拉丁 |
Chloroxylenol-d6
|
C647395-1mg
|
|
1407521-66-7 |
1mg
|
¥ 1750.9
|
期货,请咨询 |
阿拉丁 |
Cinnarizine-d8
|
C647390-1mg
|
≥98% |
1185242-27-6 |
1mg
|
¥ 2300.9
|
期货,请咨询 |
阿拉丁 |
Cimiracemoside C
|
C647384-5mg
|
≥99% |
256925-92-5 |
5mg
|
¥ 2020.9
|
期货,请咨询 |
阿拉丁 |
Cimiracemoside C
|
C647384-10mg
|
≥99% |
256925-92-5 |
10mg
|
¥ 3430.9
|
期货,请咨询 |
阿拉丁 |
Cys-McMMAF
|
C647381-5mg
|
≥99% |
1160590-05-5 |
5mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
Cys-McMMAF
|
C647381-1mg
|
≥99% |
1160590-05-5 |
1mg
|
¥ 4400.9
|
期货,请咨询 |
阿拉丁 |
Cevipabulin
|
C647369-5mg
|
≥98% |
849550-05-6 |
5mg
|
¥ 1680.9
|
期货,请咨询 |
阿拉丁 |
Cevipabulin
|
C647369-50mg
|
≥98% |
849550-05-6 |
50mg
|
¥ 8880.9
|
期货,请咨询 |
阿拉丁 |
Cevipabulin
|
C647369-10mg
|
≥98% |
849550-05-6 |
10mg
|
¥ 2880.9
|
期货,请咨询 |
阿拉丁 |
Cevipabulin
|
C647369-100mg
|
≥98% |
849550-05-6 |
100mg
|
¥ 11400.9
|
期货,请咨询 |
阿拉丁 |
Contezolid acefosamil sodium
|
C647354-5mg
|
≥99% |
1807365-35-0 |
5mg
|
¥ 9200.9
|
期货,请咨询 |
阿拉丁 |
Contezolid acefosamil sodium
|
C647354-10mg
|
≥99% |
1807365-35-0 |
10mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |
CPI-455
|
C647333-5mg
|
≥98% |
1628208-23-0 |
5mg
|
¥ 855.9
|
期货,请咨询 |
阿拉丁 |
CPI-455
|
C647333-50mg
|
≥98% |
1628208-23-0 |
50mg
|
¥ 4240.9
|
期货,请咨询 |
阿拉丁 |
CPI-455
|
C647333-25mg
|
≥98% |
1628208-23-0 |
25mg
|
¥ 2650.9
|
期货,请咨询 |
阿拉丁 |
CPI-455
|
C647333-1mg
|
≥98% |
1628208-23-0 |
1mg
|
¥ 453.9
|
期货,请咨询 |
阿拉丁 |